Epidemiology of Heart Failure
Heart failure affects more than 64 million people worldwide and represents a global pandemic with significant morbidity, mortality, and economic burden. 1
Global Prevalence and Incidence
Prevalence: Heart failure affects approximately 64.3 million people globally as of 2017, with estimates ranging from 0.2% to 17.7% depending on the population studied and diagnostic criteria used. 1, 2
Incidence trends: The incidence of heart failure has stabilized or is declining in industrialized countries, but prevalence continues to rise due to population aging, improved survival from ischemic heart disease, and effective evidence-based therapies that prolong life. 1, 3
Incidence rates: Collapsed estimates range from 0.1% to 4.3% annually, with substantial variation based on age groups and geographic location. 2
Demographic Patterns
Age distribution: Heart failure predominantly affects older adults, with the highest prevalence among those aged 65 years and older. 2
Emerging concern in younger adults: Alarming trends show increasing heart failure incidence in relatively young populations, possibly related to rising obesity rates. 4
Gender and racial disparities: Major disparities persist, particularly among younger Black men and women who experience higher occurrence rates and worse outcomes. 5
Ejection Fraction Phenotypes
Shifting case mix: A clear transition toward heart failure with preserved ejection fraction (HFpEF, EF ≥50%) has occurred, representing an increasing proportion of the total heart failure burden. 1, 4
Classification system: Heart failure is now categorized into three main phenotypes: HFrEF (EF ≤40%), HFmrEF (EF 41-49%), and HFpEF (EF ≥50%), with a fourth category of HF with improved EF defined as baseline EF ≤40% with ≥10 point increase to >40%. 1
Mortality and Hospitalization
One-year case fatality: Ranges from 4% to 45% with an average of 33% overall and 24% for studies across all adult ages, indicating heart failure remains a high-mortality condition. 2
Hospitalization burden: Heart failure is the leading cause of hospitalization in the Medicare population, accounting for more than 1 million admissions annually in the United States. 6
Persistent burden: Despite advances in treatment, the burden of mortality and hospitalization remains largely unabated. 5
Economic Impact
- Healthcare expenditures: In 2012, the total cost for heart failure was estimated at $30.7 billion in the USA, with projections suggesting an increase to $69.8 billion by 2030 (127% increase), amounting to approximately $244 per US adult. 1
Geographic Variations
Data gaps: Substantial lack of data exists from developing countries, where heart failure exhibits different features compared to the Western world. 1
Low- and middle-income countries: Evidence suggests the number of heart failure patients may be rising in these regions, struggling under the double burden of communicable diseases and conditions associated with Western-type lifestyles. 4
Limited comprehensive data: Disparities exist in epidemiological understanding of heart failure burden in Africa, South America, and parts of Asia due to lack of comprehensive surveillance. 1, 3
Key Clinical Pitfalls
Heterogeneity in studies: Diagnostic criteria, case ascertainment strategies, and demographic breakdowns vary widely between epidemiological studies, making direct comparisons challenging. 2
Recognition challenges: Heart failure with preserved ejection fraction is increasingly recognized but historically underdiagnosed, contributing to apparent shifts in epidemiological patterns. 4
Multimorbidity context: Heart failure increasingly occurs within a context of aging and multimorbidity, complicating both diagnosis and management. 5